Physician profile
Sheetal Malik
NPI 1669413712
$136,632.39
in general payments reported to CMS, 2019-2025
7 companies · $1,418 in 2025
The $1,418 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.18 · 2020: $18K · 2021: $45K · 2022: $42K · 2023: $16K · 2024: $15K · 2025: $1,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $26K · Travel and Lodging: $3,571 · Food and Beverage: $1,466 · Education: $51.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $26,400.00 |
| Travel and Lodging | $3,571.29 |
| Food and Beverage | $1,466.06 |
| Education | $51.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $131,532.55 | 2020-2025 | Xcopri |
| Supernus Pharmaceuticals, INC. | $4,863.13 | 2020-2021 | |
| Neuropace, INC. | $125.39 | 2024 | |
| Livanova USA, INC. | $38.37 | 2019-2020 | |
| Abbvie INC. | $35.32 | 2021-2024 | |
| Neurelis, INC. | $23.70 | 2025 | Valtoco |
| Aucta Pharmaceuticals, INC. | $13.93 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheetal Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.